ChemScene‑18 Novelty drug‑like Library
| Cat. No. : CS-L943 |
|---|
| （37030） |
| Library Contents: |
| ChemScene-18 stands for Medicinal Chemistry Evolution 2018, which was first published in Journal of Medicinal Chemistry in 2019 for assessing molecular novelty and three-dimensional complexity. Developed based on Clarivate global pharmaceutical patent database, this descriptor was constructed via big-data analysis covering 28,161 patented lead compounds, 1,370 approved drugs and nearly 30,000 preclinical-to-phase III drug candidates from 23 top pharmaceutical companies worldwide between 1950 and 2018, followed by structural clustering and removal of redundant outdated scaffolds for data denoising. Its scoring system integrates five core structural features including aromatic ring (AR), aliphatic heterocycle (NAR), chiral center (CHIRAL), spiro atom (SPIRO), cyclic and acyclic sp³ carbon ratio together with a quadratic topological correction factor. Breaking the limitations of the single Fsp³ parameter, ChemScene-18 effectively distinguishes conventional flat aromatic scaffolds from modern 3D-enriched novel chemotypes, overcoming typical drawbacks of traditional compound libraries such as scaffold redundancy, low screening hit rates and poor compatibility with allosteric and PPI-related difficult targets. This library contains over 37,000 structurally diverse compounds with favorable overall drug-likeness, suitable for high-throughput screening against canonical targets including kinases, GPCRs and proteases as well as challenging allosteric and PPI targets. Compounds comply with the developmental trend of modern novel drug discovery, supporting routine primary screening as well as early hit identification of allosteric modulators and PPI inhibitors, serving as an efficient screening resource for early-stage innovative drug discovery. |
| Size (Pre-dissolved DMSO or Solid) | Stock | Price |
|---|---|---|
| In-stock | Get quote |
Products are for research use only. Not for human use. We do not sell to patients.
Bulk Inquiry
CollapseYour information is safe with us. * Required Fields
Data Sheet
Description & Advantages
Composition
| Formulation: | A compound library contains over 30,000 highly novel drug-like molecules filtered by MCE‑18 (Medicinal Chemistry Evolution 2018), supporting innovative drug discovery for both conventional targets and challenging target. |
|---|---|
| Container: | 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode. |
| Storage: | -80°C |
| Shipping: | Blue ice or dry ice |
• A unique collection of 3,7000 drug-like compounds with highly novel, supporting innovative drug discovery for both conventional targets and challenging targets .
• Screened by MCE-18 empirical criteria, it is applied to the screening of both conventional targets and challenging targets.
• All compounds are available off the shelf.
• All compounds are validated by LC-MS or NMR to ensure high purity and quality.
Browsing History
| Tags:ChemScene‑18 Novelty drug‑like Library supplier, ChemScene‑18 Novelty drug‑like Library purchase, ChemScene‑18 Novelty drug‑like Library manufacturer, ChemScene‑18 Novelty drug‑like Library sigma, ChemScene‑18 Novelty drug‑like Library distributor, cost, ChemScene‑18 Novelty drug‑like Library buy, ChemScene‑18 Novelty drug‑like Library for sale |